AK-001 is a human-derived IgG1 antibody targeting Siglec-8. VRC-01 is applicable for studies on chronic rhinosinusitis with nasal polyps. For the isotype control of AK-001, refer to HumanIgG1kappa (Isotype Control).
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted